Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients

Journal of Diabetes Investigation

Volumn 5, Issue 1, 2014, Pages 3-13

  Katakami, Naoto ^a   Kaneto, Hideaki ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular diseases; Carotid ultrasound; Diabetes mellitus

Indexed keywords

ARTERIAL WALL THICKNESS; B SCAN; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CLINICAL PRACTICE; DIABETIC PATIENT; DISEASE COURSE; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; NON INVASIVE MEASUREMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING;

EID: 84896697634     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12106     Document Type: Review

References (52)

1. Nesto RW, Phillips RT. Asymptomatic myocardial ischemia in diabetic patients. Am J Med 1986; 80: 40-47.
2. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of Ischemia in Asymptomatic Diabetics Investigators the DIAD study. Diabetes Care 2004; 27: 1954-1961.
3. van Dieren S, Peelen LM, Nöthlings U, et al. External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 2011; 54: 264-270.
4. Simmons RK, Coleman RL, Price HC, et al. Performance of the UK prospective diabetes study risk engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC- Norfolk cohort. Diabetes Care 2009; 32: 708-713.
5. Stephens JW, Ambler G, Vallance P, et al. Cardiovascular risk and diabetes. Are themethods of risk prediction satisfactory? Eur J Cardiovasc Prev Rehabil 2004; 11: 521-528.
6. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
7. Joint committee with the guidelines subcommittee of the Japan Academy of Neurosonology for ultrasonic assessment of carotid artery disease and the subcommittee for research into methods of screening atherosclerotic lesions. Guidelines for ultrasonic assessment of carotid artery disease: preliminary report. Neurosonology 2002; 15: 20-33 (Japanese).
8. Terminology and Diagnostic Criteria Committee, Japan Society of Ultrasonics in Medicine. Subcommittee for Preparing Guidelines for Ultrasound Diagnosis of Carotid Artery. Standard method for ultrasound evaluation of carotid artery lesions. Jpn J Med Ultrasonics 2009; 36: 501-518.
9. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004-2006). Cerebrovasc Dis 2007; 23: 75-80.
10. Wofford JL, Kahl FR, Howard GR, et al. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 1991; 11: 1786-1794.
11. Hulthe J, Wikstrand J, Emanuelsson H, et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997; 28: 1189-1194.
12. Kasami R, Kaneto H, Katakami N, et al. Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease. Diabetes Care 2011; 34: 468-470.
13. Irie Y, Katakami N, Kaneto H, et al. Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease. Atherosclerosis 2012; 221: 438-444.
14. Nagai Y, Metter EJ, Earley CJ, et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 1998; 98: 1504-1509.
15. Yamasaki Y, Kwamori R, Matsushima H, et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 1995; 38: 585-591.
16. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87(Suppl II): II56-II65.
17. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23: 1752-1760.
18. Irie Y, Katakami N, Kaneto H, et al. The utility of carotid ultrasonography in identifying severe coronary artery disease in asymptomatic type 2 diabetes patients without history of coronary artery disease. Diabetes Care 2013; 36: 1327-1334.
19. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
20. Hougaku H, Matsumoto M, Handa N, et al. Asymptomatic carotid lesions and silent cerebral infarction. Stroke 1994; 25: 566-570.
21. Allan PL, Mowbray PL, Lee AJ, et al. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke 1997; 28: 348-353.
22. Wattanakit K, Folsom AR, Selvin E, et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2005; 180: 389-397.
23. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Atheroscler Thromb 1991; 11: 1245-1249.
24. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432-1437.
25. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
26. Hodis HN, Mack WJ, Labree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262-269.
27. Yamasaki Y, Kodama M, Nishizawa H, et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000; 23: 1310-1315.
28. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459-467.
29. Yoshida M, Mita T, Yamamoto R, et al. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care 2011; 35: 178-180.
30. Katz R. Biomarkers and surrogate markers: an FDA perspective. NeuroRx 2004; 1: 189-195.
31. Espeland MA, O'Leary DH, Terry JG, et al. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005; 10: 3.
32. Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke 2007; 38: 2887-2894.
33. Goldberger ZD, Valle JA, Dandekar VK, et al. Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis. Am Heart J 2010; 160: 701-714.
34. Costanzo P, Perrone-Filardi P, Vassallo E, et al. Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol 2010; 56: 2006-2020.
35. Lorenz MW, Polak JF, Kavousi M, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012; 379: 2053-2062.
36. Salonen R, Salonen JT, et al. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225-231.
37. Heiss G, Sharrett RA, Barnes R, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991; 134: 250-256.
38. Mannnami T, Konishi M, Baba S, et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke 1997; 28: 518-525.
39. Okada M, Miida T, Hama H, et al. Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects. Intern Med 2000; 39: 362-368.
40. Wagenknecht LE, D'Agostino RB, Haffner SM, et al. Impaired glucose tolerance, Type 2 diabetes, and carotid wall thickness. The insulin resistance atherosclerosis study. Diabetes Care 1998; 21: 1812-1818.
41. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2005; 23: 609-616.
42. Yokoyama H, Katakami N, Yamasaki Y. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke 2006; 37: 2420-2427.
43. Katakami N, Yamasaki Y, Hayaishi-Okano R, et al. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia 2004; 47: 1906-1913.
44. Matsumoto K, Sera Y, Abe Y, et al. Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes Res Clin Pract 2004; 64: 225-228.
45. Koshiyama H, Shimono D, Kuwamura N, et al. Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 3452-3456.
46. Davidson M, Meyer PM, Haffner S, et al. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation 2008; 117: 2123-2130.
47. Yamasaki Y, Katakami N, Furukado S, et al. Long term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. J Atheroscler Thromb 2010; 17: 1132-1140.
48. Temelkova-Kurktschiev TS, Koehler C, Henkel E, et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830-1834.
49. Esposito K, Ciotla M, Carleo D, et al. Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 1345-1350.
50. Yamasaki Y, Katakami N, Hayaishi-Okano R, et al. Alpha-glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Crin Pract 2005; 67: 204-210.
51. Esposito K, Giugliano D, Nappo F, et al. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004; 110: 214-219.
52. Mita T, Watada H, Shimizu T, et al. Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol 2007; 27: 2456-2462.